BioRestorative concludes Phase II BRTX-100 trial enrolment for cLDD
The trial enrolled 99 patients across 15 sites in the US.
Clinical Trials Arena
CKD-HPT, HP and HK market to reach $4bn across 7MM by 2034
7MM autism spectrum disorder market to reach $2bn by 2034
2025 dominates for GLP-1 trial activity
Rise of ultra-processed food is detriment to global health
Measles-free status of Canada revoked
Obstructive sleep apnea independently associated with cerebral microbleeds
IDWeek 2025: EL219 shows favourable safety and PK profile in Phase I studies
